Di-Benzoyl-L-Tartaric Acid Monohydrate, commonly known as (-)-Dibenzoyl-L-tartaric acid monohydrate (L-DBTA), is a chiral auxiliary used in the resolution of racemic mixtures. This compound is highly effective in facilitating the synthesis of enantiomerically pure compounds and is a valuable reagent in pharmaceutical and organic synthesis.
Di-Benzoyl-L-Tartaric Acid Monohydrate, commonly known as (-)-Dibenzoyl-L-tartaric acid monohydrate (L-DBTA), is a chiral auxiliary used in the resolution of racemic mixtures. This compound is highly effective in facilitating the synthesis of enantiomerically pure compounds and is a valuable reagent in pharmaceutical and organic synthesis.
Pharmaceutical
Pharmaceutical Actives & Precursors
Intermediates & Precursors
Chemical Properties & Specifications
H319: Causes serious eye irritation.
P264: Wash hands thoroughly after handling. P280: Wear eye protection/face protection. P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing.
Used as a chiral resolving agent in the synthesis of enantiomerically pure pharmaceutical compounds such as ramelteon, a sleep aid.
Employed in asymmetric synthesis to induce chirality in a wide range of organic reactions, particularly in the synthesis of complex molecules with high stereoselectivity.
Utilized in the development of chiral compounds for therapeutic applications and other bioactive molecules.
TSCA Registration: Registered under the Toxic Substances Control Act. EINECS Number: 220-374-0, confirming compliance with European chemical inventory standards.
Store in a cool, dry, and well-ventilated place, away from incompatible substances.
Available in various quantities, typically in 50 kg net fiber drums for bulk applications.